SESSION TYPE: DVT/PE/Pulmonary Hypertension Posters IIPRESENTED ON: Wednesday, October 24, 2012 at 01:30 PM - 02:30 PMPURPOSE: Controversy exists regarding the appropriate role of electrocardiography (ECG) in pulmonary arterial hypertension (PAH). Little information exits regarding ECG characteristics...
Pulmonary arterial hypertension (PAH) is a chronic and progressive disease leading to right heart failure and ultimately death if untreated. The first classification of PH was proposed in 1973. In 2008, the fourth World Symposium on PH held in Dana Point
Deep phenotyping the right ventricle (RV) is essential for understanding the mechanisms of adaptive and maladaptive RV responses to pulmonary hypertension (PH). In this study, feature selection coupled with machine learning classification/ranking of specific cardiac magnetic resonance imaging (MRI) feature...
Porto-pulmonary hypertension (POPH) is defined by the development of PAH associated with increased pressure in the portal circulation [33,34]. Prospective hemodynamic studies have shown that 2-6% of patients with portal hypertension had PH [35,36]. However, RHC is mandatory for the diagnosis of...
Group 1: Pulmonary arterial hypertension (PAH) can be idiopathic (i.e., primary pulmonary hypertension) or due to congenital left to right intracardiac shunts, portal hypertension, persistent pulmonary hypertension of the newborn, collagen vascular diseases, HIV infection. ...
During anti-tumor treatment, lung cancer may exacerbate pre-existing PE, and when combined with infection or tumor progression, it remains uncertain whether anti-tumor therapies can lead to the chronic progression of acute PE or its conversion to chronic pulmonary hypertension. Furthermore, the ...
Microscopic Findings Although many cases ofpulmonary hypertensionare diagnosed without lung biopsy, pathology can play a critical role in the diagnosis of patients with atypical clinical presentations. A common change in PAH is medial hypertrophy of arterial walls (Fig. 7.20). In children, muscularizat...
Patients gradually develop pulmonary hypertension (over years). Symptoms[3–5,11] Presentation varies significantly. High suspicion must be maintained given the risks of complications and mortality . Can be asymptomatic (incidentally found on imaging) Massive PE presents with hemodynamic instability/ shock...
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process in distal pulmonary arteries, as well as vasoconstriction and in si
OBJECTIVE: To describe an early experience of treating 40 children with the dual endothelin receptor antagonist bosentan, which is known to be safe and effective in adults with pulmonary hypertension (PH). DESIGN: In this retrospective, observational study the UK Service for Pulmonary Hypertension for...